O ne in 7 patients suffers a major complication or death after coronary artery bypass graft surgery (CABG), 1 and available cardiac surgery risk scores are often not able to identify these patients in advance. Identification of highrisk patients and subsequent tailoring of the revascularization strategy and postoperative management may be aided by an assessment of cardiac structure and function, such as by echocardiography. However, risk scores encompass very few echocardiographic parameters; the Society of Thoracic Surgeons (STS) risk score 1 includes left ventricular ejection fraction (LVEF) and significant valvular regurgitation or stenosis, whereas the EuroSCORE 2 includes LVEF and pulmonary arterial hypertension. a level IIb recommendation (usefulness less well established) in a limited subset of patients with recent anterior myocardial infarction. Furthermore, the 2011 ACC/AHA/American Society of Echocardiography (ASE) Appropriateness Criteria 5 provide recommendations for echocardiography before noncardiac surgery but do not address echocardiography before CABG.
No previous studies thoroughly evaluated the prognostic information that can be gained from a comprehensive preoperative echocardiogram. Such a study would demonstrate the independent value of each parameter, and the incremental value of the echocardiogram as a whole when added to traditional risk scores. With this new information, guideline committees would have a stronger evidence base on which to justify more definitive recommendations. Given this context, the objective of this study was to identify echocardiographic predictors of mortality and major morbidity in patients undergoing isolated CABG, and to determine the incremental prognostic value of the echocardiogram in addition to traditional risk scores.
Methods

Study Design
A cohort of patients undergoing isolated CABG at 2 university hospitals in the United States and Canada between 2007 and 2011 was assembled. Preoperative echocardiograms were reviewed to test the hypothesis that echocardiographic parameters would add incremental value above traditional cardiac surgery risk scores to predict postoperative mortality or major morbidity. A comprehensive echocardiographic panel was measured in the derivation cohort to identify optimal parameters, and subsequently verified in the validation cohort.
Setting
The derivation cohort consisted of consecutive patients who underwent isolated CABG at the Massachusetts General Hospital between January 1, 2007 and December 31, 2009 . The validation cohort consisted of consecutive patients who underwent isolated CABG at the Jewish General Hospital between September 1, 2010 and July 11, 2011. Patients in both cohorts were followed from the time of their index admission to hospital discharge; additionally, patients in the derivation cohort were followed forward for vital status up to July 1, 2011.
Participants
The inclusion criteria were as follows: (1) isolated CABG defined as coronary artery bypass surgery without concomitant repair or replacement of the heart valves or great vessels, and (2) preoperative transthoracic echocardiogram performed at the study center ≤30 days before surgery. Because echocardiographic images were reanalyzed for the purpose of this study, patients were excluded if they only had echocardiographic reports from an outside center or if their digital echocardiographic images could not be retrieved for technical reasons.
Predictor Variables
A comprehensive list of quantitative parameters of left-and right-sided chamber size, geometry, systolic and diastolic function, and valvular function were measured from the preoperative echocardiogram. The echocardiographic protocol and normal reference limits adhered to the guidelines of the American Society of Echocardiography. [6] [7] [8] [9] [10] Right and left atrial areas were measured at end-systole in the apical 4-chamber view; left atrial height was also measured to calculate left atrial volume using the single-plane area-length method. Right ventricular (RV) area was measured at end-diastole and end-systole in the apical . Pulmonary artery systolic pressure (PASP) was measured by continuous wave Doppler of the tricuspid regurgitation with 10 mm Hg added for right atrial pressure. LVEF and volumes were measured using the biplane Simpson method. Left ventricular (LV) mass was measured using the Devereux method. LV diastolic function was assessed using a multi-parametric approach including pulsed Doppler of the mitral and pulmonary vein inflow, tissue Doppler of the medial and lateral annulus, and left atrial volume. Valvular regurgitation and stenosis were assessed using a multi-parametric approach as reported by the echocardiography reader, including mean and peak gradients, color Doppler jet appearance, vena contracta, and proximal isovelocity shell area (PISA) where applicable.
Measurements were performed in duplicate by 2 independent echocardiography readers (J.A., A.F., C.C., A.S.), and arbitrated by a third senior reader (M.H.P., L.G.R.). All readers were cardiologists trained in echocardiography. To ensure accuracy and consistency of measurement techniques, readers participated in focused training sessions and quality audits throughout the study. Readers were blinded to the clinical data and outcomes when interpreting the echocardiograms.
Outcome Variables
The primary outcome was a composite of in-hospital mortality or major morbidity defined according to the STS data definitions as any 1 of the following: all-cause death, stroke, renal failure, prolonged ventilation, deep sternal wound infection, or need for reoperation.
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The secondary outcome was long-term all-cause mortality defined as death from any cause occurring from the time of cardiac surgery to the end of follow-up. There were no patients lost to follow-up for the primary or secondary outcomes.
Data Sources
Echocardiographic measurements were performed on the digital echocardiographic images stored on dedicated servers. Echocardiograms were performed with the Philips IE33, Sonos 7500, or GE Vivid 7 machines and analyzed on the Xcelera workstation (Philips Medical Systems, Andover, MA) at the derivation site, and with the GE Vivid 7 machine and EchoPAC workstation (GE, Milwaukee, WI) at the validation site. Clinical data, including in-hospital outcomes, were extracted according to the STS Adult Cardiac Surgery Database. Vital status was extracted from the Social Security Death Index by way of the Research Patient Data Registry (Partners Healthcare, Boston, MA).
Study Size
Assuming a baseline incidence of mortality or major morbidity of 14.4%, 1 430 patients were needed to demonstrate an odds ratio of at least 1.5 with a 2-sided alpha of 0.05 and a beta of 0.2 in our multivariable regression model. Moreover, because the multivariable model was prespecified to contain up to 11 covariables (10 echocardiographic parameters plus the STS-Predicted Risk of Mortality or Major Morbidity [STS-PROMM]), ≈110 events were required to maintain an appropriate covariable:event ratio to avoid overfitting. the logit of the primary outcome (y axis) and the resulting graphical plot was inspected for linearity. Because clinicians often use cutoffs in day-to-day practice, echocardiography variables were also dichotomized according to accepted normal reference limits and analyses were presented using both continuous and dichotomized predictors.
The multivariable echocardiographic model was a priori prespecified to include 1 parameter from each of the following domains: right atrial size, RV size, RV systolic function, RV diastolic function or MPI, PASP, tricuspid regurgitation, left atrial size, LV size, LV systolic function, LV diastolic function, LV mass, and mitral regurgitation. Indexed parameters were used and volumes/areas were favored over linear dimensions for cavity size. Right and left atrial size were removed from the model because they were found to be intermediate factors in the causal pathway between diastolic dysfunction and adverse outcomes, and also between tricuspid/mitral regurgitation and adverse outcomes (leading to model instability and overadjustment bias when entered). 14 For the primary outcome, a multivariable logistic regression model was used to identify the optimal echocardiographic parameters to predict in-hospital mortality or major morbidity. For the secondary outcome, a multivariable Cox proportional hazards model was used to identify the optimal echocardiographic parameters to predict all-cause mortality. The proportionality of hazards assumptions was tested based on Schoenfeld residuals. Of note, these echocardiographic models did not contain clinical variables or the STS-PROMM.
To test the incremental predictive value for mortality or major morbidity, the optimal echocardiographic parameters identified in the above model were then entered in a subsequent model that contained the STS-PROMM. Model performance statistics were calculated before and after addition of the echocardiographic parameters to STS-PROMM. These statistics included the c-statistic for discrimination, Aikaikes Information Criterion (AIC) for global fit, Net Reclassification Improvement, and Integrated Discrimination Improvement (IDI) for reclassification. 15 For the Net Reclassification Improvement, the Q1 and Q3 were used to define STS-PROMM cutoffs: low risk 0% to 10%, intermediate risk 10% to 25%, and high risk >25%. The AIC approach with forward selection was used to select the echocardiographic variables for the model, with the optimal model being that which minimized the AIC.
The model selected and coefficients identified in the derivation cohort were applied to predict the risk of mortality or major morbidity in the external validation cohort. The c-statistic for these predicted probabilities in the validation cohort was calculated and compared with the c-statistic for the STS-PROMM alone.
Sensitivity analysis was performed in which the echocardiographic parameters were entered in a model containing individual clinical covariables rather than the composite STS-PROMM. The clinical covariables were chosen to be those with the highest coefficients in the STS-PROMM model (age, female, diabetes mellitus, chronic kidney disease, chronic lung disease, peripheral arterial disease, cerebrovascular disease, atrial fibrillation, previous cardiac surgery). Measurements were >90% to 95% complete for all echocardiographic parameters, with the exception of PASP (74% complete, not measurable when no tricuspid regurgitation). Therefore, a sensitivity analysis was performed in which multiple imputation was used to derive missing values for PASP. All analyses were performed with STATA 12 (College Station, TX).
Results
Derivation Cohort
A total of 1150 patients underwent isolated CABG at the derivation site between 2007 and 2009, of which 667 had available echocardiograms performed at the study center ≤30 days before surgery (mean 5.6±5.8 days before surgery; Figure 1 ). Those who did not have available echocardiograms at the study center were excluded; they had determination of left ventricular function by angiocardiography (n=387), echocardiography at another center (n=49), nuclear medicine (n=33), or other modality (n=14), and were less likely to present with myocardial infarction, have heart failure, or require urgent surgery (Table I in the online-only Data Supplement).
Baseline clinical characteristics are shown in Table 1 . The mean age was 67.2±11.1 years, with 10.0% octogenarians and 22.8% females. Patients were evenly distributed in low-risk (29% with STS-PROMM 0% to 9%), intermediate-risk (46% with STS-PROMM 10% to 25%), and high-risk (25% with STS-PROMM ≥25%) categories. One hundred four (15.6%) postoperative mortalities or major morbidities were observed during the index hospitalization.
The preoperative echocardiographic parameters are shown in Table 2 . The optimal echocardiographic model to predict in-hospital mortality or major morbidity consisted of the following (continuous predictors): restrictive LV diastolic filling (odds ratio [OR], 2.39; 95% confidence interval [CI], 1.26-4.55), RV fractional area change (OR, 0.73; 95% CI, 0.56-0.95), RV myocardial performance index (OR, 1.44; 95% CI, 1.10-1.90), and mitral regurgitation (OR, 1.44; 95% CI, 1.04-2.01), although mitral regurgitation did not reach statistical significance when dichotomized at the moderate severity threshold ( Table 3) .
Addition of these echocardiographic parameters to the STS-PROMM resulted in a net improvement in model performance as evidenced by an increase in c-statistic from 0.68 to 0.73, a decrease in AIC from 543 to 470, an Net Reclassification Improvement of 27.5% (95% CI, 12.8-42.1%), and an IDI of 5.9% (95% CI, 2.8-8.9%) ( Figure 2 ). After adjusting for STS-PROMM, restrictive LV diastolic filling (OR, 2.38; 95% CI, 1.21-4.70) and RV fractional area change (OR, 0.73; 95% CI, 0.55-0.98) remained independently predictive.
Seventy-three (10.9%) deaths were observed over a median follow-up of 3.2 years (Q1 2.5, Q3 3.9 years). In the Cox proportional hazards model, 2 echocardiographic parameters (Table 3) . In particular, patients with a preoperative PASP ≥50 mm Hg had a 3-fold increase in mortality (HR, 3.54; 95% CI, 1.95, 6.42; Figure 3 ).
In sensitivity analyses, the same echocardiographic predictors were identified when individual clinical covariables were used instead of the composite STS-PROMM to adjust for baseline characteristics (Tables II and III in the online-only  Data Supplement) , and when multiple imputation was used to derive values for missing PASP (n=175 missing as a result of insufficient tricuspid regurgitation jet envelope).
Validation Cohort
A total of 236 patients underwent isolated CABG at the validation site, of which 187 had available preoperative echocardiograms 
Discussion
Our study has demonstrated the prognostic impact of a comprehensive echocardiogram in patients undergoing CABG. Preoperative RV dysfunction and restrictive LV filling emerged as powerful predictors of mortality or major morbidity after CABG, whereas RV dysfunction and pulmonary hypertension predicted long-term mortality over 3.2 years. Importantly, addition of these echocardiographic parameters to the STS risk score resulted in a net improvement in model performance, signifying that echocardiography yielded incremental value.
The incremental value provided by the echocardiogram above traditional risk scores was found to be substantive. The increase in c-statistic of 0.03 to 0.05 and IDI of 5.9% compare favorably with other commonly used prognostic tests, such as coronary artery calcium testing (increase in c-statistic +0.04, IDI 1.5%) or high-sensitivity c-reactive protein testing (increase in c-statistic +0.01, IDI 0.2%) above traditional risk factors to predict incident cardiovascular events. 16 The modest baseline c-statistic of 0.68 to predict major morbidity in this study is consistent with previous reports (c-statistic 0.65-0.70 to predict morbidity versus 0.75-0.80 to predict mortality) 17 and confirms the limitations in predicting who will suffer a postoperative complication.
Inclusion of RV dysfunction and restrictive LV filling in risk scores would lead to refined estimates of operative risk, which have historically been less accurate in certain patients, particularly the elderly. 17 Using echocardiography to improve risk prediction would allow clinicians and patients to be better informed in their shared decision-making and planning. Because higher-risk patients are often those who derive greater benefits from revascularization, the main clinical utility of echocardiography in identifying higher-risk patients would not be to withhold CABG from such patients but rather to tailor the revascularization strategy to the individual patient. For example, a patient found to have preoperative RV dysfunction or restrictive LV filling may potentially benefit from a less invasive revascularization strategy (minimally invasive CABG, off-pump CABG, multivessel PCI). Carefully designed prospective studies are needed to test and validate this hypothesis.
Intraoperative transesophageal echocardiography (TEE), now commonly performed in many centers, provides valuable guidance for intraoperative management during CABG. However, the mandate and focus of the intraoperative TEE is clearly different from that of the preoperative transthoracic examination. The preoperative transthoracic examination offers a comprehensive assessment of the severity and extent of disease, and in doing so, exerts a direct influence on patient selection and revascularization strategy. The intraoperative TEE is performed at a time when the revascularization strategy has in large part already been determined and would be impractical to change. Thus, the preoperative transthoracic examination and the intraoperative TEE serve complimentary (as opposed to redundant) roles.
Beyond guiding the overall revascularization strategy, specific interventions aimed at a given echocardiographic abnormality could be used. For the severely dysfunctional RV (abnormal RV FAC), right ventricular assist devices have been successfully used as adjuncts to CABG. 18, 19 For the mildly dysfunctional RV, ischemic preconditioning by transient aortic cross-clamping and reperfusion showed positive results, although these have yet to be applied in clinical practice. 20 Revascularization of intermediate right coronary artery stenoses does not seem to be a predictor of RV recovery after CABG. 21, 22 For patients with pulmonary hypertension, pulmonary vasodilators have been shown to improve outcomes. 23, 24 For the restrictive LV, milrinone has had mixed results 25, 26 whereas close monitoring and optimization of volume status and filling pressures remains the mainstay.
Preoperative RV dysfunction was a strong predictor of short-and long-term outcomes after CABG. Previously, the clinical impact of preoperative RV dysfunction was unclear. One series of 74 patients showed that tricuspid annular plane systolic excursion was not predictive of death or readmission after CABG, 27 whereas another series of 41 patients with severe LV dysfunction showed that RV FAC assessed by intraoperative TEE was predictive of ventilator hours and inotrope requirements in the early postoperative period. 28 The latter study was difficult to extrapolate because RV FAC had been measured under anesthetized conditions, in a highly selected patient population, with a small sample size underpowered to detect differences in clinical endpoints (only 7 patients had an abnormal RV FAC). Our series of 667 diverse patients has shown more definitively that RV FAC assessed by resting preoperative TTE was predictive of major clinical endpoints.
In addition to RV FAC as a measure of RV systolic dysfunction, our echocardiographic protocol included RV MPI as a measure of global RV efficiency. These two measures proved to be complementary-RV FAC identified a small group of patients (5%) with overt RV hypokinesis who were at extreme risk (50% observed mortality or major morbidity), whereas RV MPI identified a larger group (24%) with subclinical RV impairment which may not otherwise be detected by visual assessment of the RV that were at high risk (26% observed mortality or major morbidity). We opted not to include measures of longitudinal RV function (tricuspid annular plane systolic excursion or tricuspid annular tissue Doppler velocity) for 2 reasons: first, these have been shown to inaccurately correlate with postoperative RV ejection fraction 29 or functional capacity 30 after cardiac surgery, and second, these require dedicated M-Mode and tissue Doppler acquisitions, which are not always available. RV FAC and MPI have the distinct advantage of being measurable offline from routinely acquired images within <5 minutes. These 2 parameters are recommended for routine clinical use by the Guidelines for the Echocardiographic Assessment of the Right Heart from the American Society of Echocardiography, 6 because their reliability and prognostic value have been extensively validated.
Restrictive LV filling, the echocardiographic hallmark of severe diastolic dysfunction, was the other independent predictor of mortality or major morbidity in our cohort. This finding is consistent with previous studies, which have consistently shown that severe but not mild or moderate diastolic dysfunction is associated with mortality and complications after CABG. [31] [32] [33] [34] The prevalence of restrictive LV filling was 6% to 10% in our 2 cohorts, in line with previous studies. This prevalence may vary depending on the patient population studied (3% in elective low-risk patients 34 up to 48% in highrisk patients with severe LV systolic dysfunction). January 22, 2013
The rationale for RV dysfunction and restrictive LV diastolic filling as determinants of postoperative mortality or major morbidity can be appreciated by reviewing the usual physiological changes after CABG. Two of the predominant disturbances are (1) altered RV contraction and relaxation observed at the time of pericardial opening, 35 and (2) increased LV stiffness attributable to myocardial edema and extrinsic compressive forces. [36] [37] [38] Thus, given the expected decline in RV performance and LV stiffness after CABG, patients with preoperative findings of abnormal RV performance or LV stiffness (severe diastolic dysfunction) are at a clear disadvantage. Conversely, CABG is associated with improved LV relaxation attributable in part to relief of ischemia, 39 which may explain why patients with preoperative findings of abnormal LV relaxation (mild-to-moderate diastolic dysfunction) do not face an increase in adverse events. Additionally, severe diastolic dysfunction as measured by a mitral inflow deceleration time <150 ms has been shown to be a surrogate marker for viability (or lack thereof) validated against dobutamine echocardiography and myocardial scintigraphy 33 ; this may explain, in part, why patients with restrictive LV filling tend to deteriorate rather than improve after CABG.
By analyzing the comprehensive echocardiogram rather than individual parameters of interest, our study was able to adjust for confounding between echocardiographic parameters. Previous studies have been limited by partial adjustment for confounding, often adjusting for basic clinical variables but no other echocardiographic variables, leading to inconsistent results. For example, the effect of low LVEF on postoperative mortality has been reported to be highly significant when adjusted for basic clinical variables [40] [41] [42] but nonsignificant when adjusted for LV size and diastolic function. 31, 43 Our data reflect this, with the effect of low LVEF being highly significant in univariate analysis (OR, 5.2; P<0.001) but nonsignificant when diastolic dysfunction and RV dysfunction were entered in the multivariable model (OR, 1.8; P=NS). Irrespective of these potential confounders, it is not surprising that LVEF was nonsignificant in our contemporary cohorts because the prognostic impact of LVEF has been steadily declining in parallel with improvements in surgical techniques and postoperative care. 44, 45 A number of limitations should be acknowledged. First, the STS composite end point used as our primary outcome is intended to capture representative major morbidities after cardiac surgery, including deep sternal wound infection, which is of questionable relevance to preoperative echocardiography. However, deep sternal wound infection contributed very few events (n=4) to the composite end point and a sensitivity analysis excluding it was unchanged. Second, follow-up echocardiography is not routinely performed after CABG, precluding the assessment of functional recovery as an outcome measure. Third, approximately one third of patients undergoing CABG in the derivation cohort and one fifth in the validation cohort did not have a recent preoperative echocardiogram; these tended to be lower risk patients. Although this nonrandom subset could have affected the generalizability of our findings, the derivation and validation cohorts still included a large number of low-risk patients who were ultimately found to derive a similar if not greater incremental value from the echocardiogram. Fourth, although a formal cost-effectiveness analysis was not performed, it is encouraging to note that the cost savings of preventing 1 postoperative major morbidity (average additive cost $40,704-62,773 46 ) would offset the cost of performing >200 preoperative echocardiograms (global cost $233 as per the 2011 ASE Coding and Reimbursement Newsletter). Fifth, because the STS-PROMM was not designed nor validated to predict long-term mortality, the incremental value of echocardiographic predictors over such a clinical risk score was not assessed for this outcome measure. Lastly, the effect of significant MR was equivocal (it was identified by the model selection procedure as 1 of 4 important predictors, yet it did not reach statistical significance), and the study was not designed to address how significant MR should be managed at the time of CABG. This remains a controversial question, which will be most appropriately answered by ongoing randomized clinical trials.
The strengths of this study include a multi-center design with derivation and validation cohorts, and a comprehensive echocardiographic protocol including right heart parameters, which had previously been less thoroughly evaluated. Our findings serve as an impetus to begin to integrate measures of RV dysfunction and severe LV diastolic dysfunction in the preoperative assessment of risk before CABG. 
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